XPO1 inhibitor induced apoptosis in triple-negative breast cancer by promoting survivin nuclear accumulation and decreasing survivin cytoplasmic protein levels through repression of survivin transcription [33]. Here, BIRC5 is linked to triple-negative breast carcinoma.